Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 13, 2016
Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation
Carmen Di Grazia, Sarah Pozzi, Simona Geroldi, et al.
Journal of Hematology & Oncology
|
May 29, 2023
Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT
Arnon Nagler, Myriam Labopin, Didier Blaise, et al.
Annals of Hematology
|
July 4, 2014
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia
Enrico De Astis, Marino Clavio, Anna Maria Raiola, et al.
American Journal of Hematology
|
November 4, 2020
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen
Patrizia Chiusolo, Stefania Bregante, Sabrina Giammarco, et al.
The Journal of Antimicrobial Chemotherapy
|
February 17, 2024
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring
Malgorzata Mikulska, Monica Melchio, Alessio Signori, et al.
American Journal of Hematology
|
July 12, 2025
Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Yishan Ye, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Bone Marrow Transplantation
|
June 29, 2026
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT
Sarah Kayser, Arnon Nagler, Allain Thibeault Ferhat, et al.
Bone Marrow Transplantation
|
February 5, 2025
The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide
Alexandros Spyridonidis, Myriam Labopin, Bipin P Savani, et al.
Haematologica
|
October 13, 2004
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation
Andrea Bacigalupo, Maria Pia Sormani, Teresa Lamparelli, et al.
American Journal of Hematology
|
May 23, 2024
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Raynier Devillier, Jacques-Emmanuel Galimard, Didier Blaise, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 13, 2016
Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation
Carmen Di Grazia, Sarah Pozzi, Simona Geroldi, et al.
Journal of Hematology & Oncology
|
May 29, 2023
Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT
Arnon Nagler, Myriam Labopin, Didier Blaise, et al.
Annals of Hematology
|
July 4, 2014
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia
Enrico De Astis, Marino Clavio, Anna Maria Raiola, et al.
American Journal of Hematology
|
November 4, 2020
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen
Patrizia Chiusolo, Stefania Bregante, Sabrina Giammarco, et al.
The Journal of Antimicrobial Chemotherapy
|
February 17, 2024
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring
Malgorzata Mikulska, Monica Melchio, Alessio Signori, et al.
American Journal of Hematology
|
July 12, 2025
Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Yishan Ye, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Bone Marrow Transplantation
|
June 29, 2026
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT
Sarah Kayser, Arnon Nagler, Allain Thibeault Ferhat, et al.
Bone Marrow Transplantation
|
February 5, 2025
The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide
Alexandros Spyridonidis, Myriam Labopin, Bipin P Savani, et al.
Haematologica
|
October 13, 2004
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation
Andrea Bacigalupo, Maria Pia Sormani, Teresa Lamparelli, et al.
American Journal of Hematology
|
May 23, 2024
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Raynier Devillier, Jacques-Emmanuel Galimard, Didier Blaise, et al.
Page
of 9